Doctors Need Solid Understanding of Hereditary Cancer When Prescribing Lynparza for Breast Cancer: Prof.

Prof. Akihiro Sakurai, Sapporo Medical University School of Medicine Doctors should adequately understand the impact of heredity and explain it to patients when they prescribe AstraZeneca’s oral PARP inhibitor Lynparza (olaparib), said Akihiro Sakurai, professor of genetic medicine at Sapporo...read more